Anti-Counterfeit Pharmaceutical Packaging Market Size & Share, by Technology (Holograms, Security Printing & Graphics, Security Ink Coatings, RFID, Mass Encoding); Feature (Tampered Evidence, Forensic Makers, Overt Features, Covert Features, Track & Trace Technologies) - Global Supply & Demand Analysis, Growth Forecasts, Statistics Report 2025-2037

  • Report ID: 3043
  • Published Date: Dec 24, 2024
  • Report Format: PDF, PPT

Global Market Size, Forecast, and Trend Highlights Over 2025-2037

Anti-Counterfeit Pharmaceutical Packaging Market size was valued at USD 165.99 billion in 2024 and is expected to reach USD 715.93 billion by 2037, expanding at around 11.9% CAGR during the forecast period i.e., between 2025-2037. In the year 2025, the industry size of anti-counterfeit pharmaceutical packaging is assessed at USD 182.78 billion.

This can be accounted to the increasing number of counterfeit products and growing demand for well-protected pharmaceutical drug packaging. According to the WHO, 1 out of every 10 medical products in developing countries is counterfeited or substandard. Amongst all the regions in the world, 42% of the reports came from Africa. Along with these, rising emphasis of manufacturers to safeguard their brand identities and stringent government regulations to prevent illegal drug channeling are also expected to drive growth to the market in the near future. Furthermore, development of innovative technologies for identification and authentication of medicines is estimated to provide impetus to the anti-counterfeit pharmaceutical packaging market in the coming years.


Get more information on this report: Request Free Sample PDF

Anti-Counterfeit Pharmaceutical Packaging Sector: Growth Drivers and Challenges

Growth Drivers

  • Strict Policy and Regulatory Landscape Leading to Rising Demand for Anti-Counterfeit Pharmaceutical Packaging
  • Rise of Development Innovate Technologies for Pharmaceutical Packaging

Challenges

  • Expensive Setup of Anti-Counterfeit Pharmaceutical Packaging Systems

Anti-Counterfeit Pharmaceutical Packaging Market: Key Insights

Base Year

2024

Forecast Year

2025-2037

CAGR

11.9%

Base Year Market Size (2024)

USD 165.99 billion

Forecast Year Market Size (2037)

USD 715.93 billion

Regional Scope

  • North America (U.S., and Canada)
  • Asia Pacific (Japan, China, India, Indonesia, Malaysia, Australia, South Korea, Rest of Asia Pacific)
  • Europe (UK, Germany, France, Italy, Spain, Russia, NORDIC, Rest of Europe)
  • Latin America (Mexico, Argentina, Brazil, Rest of Latin America)
  • Middle East and Africa (Israel, GCC North Africa, South Africa, Rest of the Middle East and Africa)

Get more information on this report: Request Free Sample PDF

Anti-Counterfeit Pharmaceutical Packaging Segmentation

The anti-counterfeit pharmaceutical packaging market can be segmented by technology into mass encoding, security printing & graphics, holograms, RFID, and security ink coatings. Out of these, the mass encoding segment is projected to hold a significant market share during the forecast period, owing to its excellent product tracking solution in several nodes of the supply chain management. However, the segment for RFID is estimated to register highest growth by the end of 2029, which can be attributed to the better tracking features and product security of this technology. Additionally, on the basis of feature, the segments for covert & overt features are evaluated to grow with a notable CAGR during the forecast period. This can be credited to the increasing adoption of covert & overt systems as they are able to offer authenticated packaging in the form of a visual representation or any other comprehensive method which is extremely hard to copy without a particular detection device.

Our in-depth analysis of the global market includes the following segments:

           By Technology

  • Holograms
  • Security Printing & Graphics
  • Security Ink Coatings
  • RFID
  • Mass Encoding

             By Feature

  • Tampered Evidence
  • Forensic Makers
  • Overt Features
  • Covert Features
  • Track & Trace Technologies
 

Want to customize this research report as per your requirements? Our research team will cover the information you require to help you take effective business decisions.

Customize this Report

Anti-Counterfeit Pharmaceutical Packaging Industry - Regional Synopsis

On the basis of regional analysis, the anti-counterfeit pharmaceutical packaging market is segmented into five major regions, including North America, Europe, Asia Pacific, Latin America and the Middle East & Africa. North America industry is anticipated to hold largest revenue share by 2037, owing to rising focus on promoting the use of sustainable anti-counterfeit packaging alternatives and presence of the majority of key players. However, the Asia Pacific is calculated to record immense growth during the forecast period on the back of the growing realization among consumers that has led to them to become more aware regarding what they are buying before consumption, which in turn is also estimated to increase the demand of these packaging in this region. In addition, rising adoption of security technologies for medicines in China alone is also expected to drive anti-counterfeit pharmaceutical packaging market growth in the region. 

Research Nester
Get more information on this report: Request Free Sample PDF

Companies Dominating the Anti-Counterfeit Pharmaceutical Packaging Landscape

    • Avery Dennison Corporation
      • Company Overview
      • Business Strategy
      • Key Product Offerings
      • Financial Performance
      • Key Performance Indicators
      • Risk Analysis
      • Recent Development
      • Regional Presence
      • SWOT Analysis
    • CCL Industries Inc.
    • DuPont de Nemours, Inc.
    • AlpVision S.A
    • SICPA HOLDING SA
    • Applied DNA Sciences Inc.
    • ATL Corp.
    • Alien Technology, LLC
    • Authentix, Inc.
    • Impinj, Inc.

In the News

  • March 2020: Avery Dennison Corporation, on March 2, 2020, announced that it has completely acquired Smartrac’s Transponder business for development and manufacture of RFID products, in a deal of around USD 226.58 million.

  • August 2020: CCL Healthcare joined hands with DoseID Consortium to expand its scope to the use of radio-frequency identification (RFID) technology in the healthcare sector.

Author Credits:  Abhishek Anil


  • Report ID: 3043
  • Published Date: Dec 24, 2024
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

In the year 2025, the industry size of anti-counterfeit pharmaceutical packaging is assessed at USD 182.78 billion.

Anti-Counterfeit Pharmaceutical Packaging Market size was valued at USD 165.99 billion in 2024 and is expected to reach USD 715.93 billion by 2037, expanding at around 11.9% CAGR during the forecast period i.e., between 2025-2037.

North America industry is anticipated to hold largest revenue share by 2037, owing to rising focus on promoting the use of sustainable anti-counterfeit packaging alternatives and presence of the majority of key players.

The major players in the market are Avery Dennison Corporation, CCL Industries Inc., DuPont de Nemours, Inc., AlpVision S.A, and others.
Anti-Counterfeit Pharmaceutical Packaging Market Report Scope
logo
  GET A FREE SAMPLE

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying
Inquiry Before Buying Request Free Sample